Novel Biomarkers of Cardiac Stress, Cardiovascular Dysfunction, and Outcomes in HIV-Infected Individuals
- 1 August 2015
- journal article
- Published by Elsevier in JACC: Heart Failure
- Vol. 3 (8) , 591-599
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected IndividualsPLOS ONE, 2012
- Inflammation, Immune Activation, and CVD Risk in Individuals With HIV InfectionJAMA, 2012
- GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cellsRespiratory Research, 2011
- N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patientsAIDS, 2011
- High-Sensitivity ST2 for Prediction of Adverse Outcomes in Chronic Heart FailureCirculation: Heart Failure, 2011
- High Levels of Soluble ST2 and Low Levels of IL-33 in Sera of Patients with HIV InfectionJournal of Investigative Dermatology, 2011
- Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs StudyEuropean Journal of Preventive Cardiology, 2010
- Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of EchocardiographyJournal of the American Society of Echocardiography, 2010
- Prognostic Value of Growth-Differentiation Factor-15 in Patients With Non–ST-Elevation Acute Coronary SyndromeCirculation, 2007
- Circulating Concentrations of Growth-Differentiation Factor 15 in Apparently Healthy Elderly Individuals and Patients with Chronic Heart Failure as Assessed by a New Immunoradiometric Sandwich AssayClinical Chemistry, 2007